We center on applying advanced molecular, bioinformatic and clinical research methods to address critical issues at the intersection of hematology, oncology, and infectious diseases. We focus on both fundamental biological mechanisms and rapid clinical translation to improve diagnosis and prognostication and prognosis of our patients.